← Evidence map

ArticleScientific reports2021

Serum HE4 and CA125 combined to predict and monitor recurrence of type II endometrial carcinoma.

Quan Quan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

13 papers cite it

2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 34737393